The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer

Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Daniel C., Cookson, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004830/
https://www.ncbi.nlm.nih.gov/pubmed/32055749
http://dx.doi.org/10.4111/icu.2020.61.S1.S3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004830/
https://www.ncbi.nlm.nih.gov/pubmed/32055749
http://dx.doi.org/10.4111/icu.2020.61.S1.S3

Ejemplares similares